Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
21.3%
% of WDNA's 91 holdings also in SYNB
55.9%
% of SYNB's 36 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus SYNB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in SYNB |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 1.9% | 3.8% | 1.9% | |
TWIST BIOSCIENCE CORP. | 3.4% | 1.7% | 1.7% | |
VERTEX PHARMACEUTICALS INC | 1.3% | 1.4% | 1.3% | |
DANAHER CORP | 1.3% | 7.2% | 1.3% | |
REGENERON PHARMACEUTICALS | 1.2% | 3.1% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to SYNB
IOVANCE BIOTHERAPEUTICS INC | 3.9% | |
FATE THERAPEUTICS INC | 3.1% | |
NOVOZYMES A/S-B SHARES | 2.4% | |
BLUEPRINT MEDICINES CORP. | 2.2% | |
BRIDGEBIO PHARMA, INC. | 2.0% | |
NATERA INC | 1.9% | |
ALCOBRA LTD | 1.7% | |
VERICEL CORPORATION | 1.7% | |
TWIST BIOSCIENCE CORP. | 1.7% | |
AGIOS PHARMACEUTICALS INC | 1.6% |
WDNA Underweight Relative to SYNB
NVIDIA CORP | -7.3% | |
THERMO FISHER SCIENTIFIC INC | -6.5% | |
DANAHER CORP | -5.9% | |
ALPHABET INC. CLASS A | -5.2% | |
BIO-RAD LABORATORIES-CL A | -4.8% | |
NOVOZYMES A/S-UNSPONS ADR | -4.6% | |
ABBVIE INC | -4.4% | |
ASCENDIS PHARMA A/S | -4.1% | |
CORTEVA INC | -3.5% | |
AVANTOR, INC. | -3.5% |